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Cooper, M. and Waldby, C.: 2014, Clinical Labor: Tissue
Donors and Research Subjects in the Global Bioecono-
my. Durham, NC: Duke University Press. 296 pages.
ISBN: 978-0-8223-5622-6. Price: $24.95.
Bioethicists, clinicians and regulators tend to conceptualise
donation of gametes and reproductive tissue and partici-
pation in clinical research as altruistic acts, performed in
order to help infertile couples or future patients. In Clinical
Labor: Tissue Donors and Research Subjects in the Global
Bioeconomy, Melinda Cooper and Catherine Waldby
challenge this conceptualisation by instead analysing these
activities as work—as an informal clinical labour that is
essential to value creation in the global bioeconomy and
often performed to make money (or, in late phase clinical
trials, to have access to otherwise unavailable healthcare).
The first chapter presents the book’s theoretical frame-
work, a ‘‘clinical labour theory of value’’, distinguishing it
from its Marxist forerunner by its emphasis on the
embodied and experimental nature of value creation. The
second chapter describes the broader historical context in
which clinical labour emerges, highlighting increasing
labour outsourcing and the shifting of risks from firms to
workers, as well as the blurring boundaries between
workplace and household. The following three chapters
focus on reproductive labour, the harnessing of human
(especially female) reproductive biology for commercial
and innovative ends. The authors first examine gamete
vending and commercial gestational surrogacy in the US,
before turning to the transnational European oocyte and
Indian surrogacy markets, and finally to the use of repro-
ductive tissue in the stem cell industries. The last three
chapters explore the experimental labour of research sub-
jects enrolled in the global clinical trial enterprise. Cooper
and Waldby detail how this labour, once typically per-
formed by prison inmates and academic hospital patients in
the US, is now increasingly outsourced to the burgeoning
Chinese and Indian economies.
The account of the internal mechanics of these informal
labour markets is combined with careful analysis of their
complex socioeconomic, political and legal preconditions.
In particular, the authors demonstrate their dependence on
populations whose vulnerability—economic (unemploy-
ment or job insecurity) or physical (lack of health insur-
ance)—make them willing to assume bodily risks in
exchange for money or healthcare. They identify the trends
towards economic liberalisation and deindustrialisation
that underlie the emergence of these populations and the
international regulations that permit their enrolment in the
global bioeconomy.
One virtue of Clinical Labor is that it reveals the brute
commercial nature of some of the bodily exchanges on which
biomedical innovation increasingly relies. It thus helps dis-
pel the air of altruism and voluntariness that surrounds these
exchanges and that arguably impedes an accurate ethical
appreciation of them. Equally valuable is its exposure of the
precarious living conditions from which clinical labour
arises. The book raises important questions for scholars
working at the intersection of bioethics and political phi-
losophy, especially concerning responsibility for social
injustice. Therefore, even though Cooper and Waldby are
critical of bioethics, regarding it as facilitating the creation of
clinical labour markets by promoting informed consent and
contractual relations between clinicians and tissue providers
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or research subjects, their book can be expected to signifi-
cantly advance bioethical debate.
One may worry that the authors stretch their analysis too
far when they classify umbilical cord blood and foetal
tissue donation and patients’ reporting of drug consumption
habits on social networking sites as ‘‘clinical labour’’. Like
the other practices they examine, these too undeniably
allow deriving scientific and commercial value from (often
burdensome) biological processes. But they are unremu-
nerated, in money or in kind, and therefore unlikely to
disproportionally enrol the underprivileged. Nor do they
expose the provider to risks other than those already
assumed. Hence, unlike other clinical labour, they lack the
character of hazardous work chosen because of economic
or medical need. This mild complaint notwithstanding,
Clinical Labor is highly recommended reading.
Erik Malmqvist
Linko¨ping, Sweden
MacKellar, C. and Betchel, C.: 2014, The Ethics of the New
Eugenics. Oxford: Berghahn. 242 pages. ISBN:
978-1782381204. Price: £60.00
The Ethics of the New Eugenics, commissioned by the
Scottish Council on Human Bioethics and authored by
Calum MacKellar and Christopher Betchel, is an ethical
evaluation of new eugenic procedures and their legal
implications. The book seeks to introduce, examine, and
analyse the new eugenics while stimulating public discus-
sion about it (pp. 28–29). It addresses ‘‘the perceived
resurgence of eugenics in the increasingly common pro-
cedures available in assisted reproductive technology’’ (p.
290). After clarifying key terms such as health, enhance-
ment, normality, therapy, and different meanings of
eugenics, the authors outline and evaluate the history of the
eugenic movement. They then describe, ethically evaluate
and present legal data for ten eugenic procedures: selection
of a reproductive partner, choosing the number of children,
adoption, sex selection, egg and sperm selection, prenatal
genetic selection, preimplantation genetic selection, human
reproductive cloning, infanticide, and genetic modification.
After looking at these specific procedures, they move to
a general discussion outlining both the arguments sup-
porting and opposing eugenics in order to ‘‘evaluate whe-
ther the novel procedures being proposed should be
welcomed or shunned’’ (p. 191). Two positive points are
presented: first that ‘‘eugenic procedures may indeed
facilitate the well-being of individuals and their families,
and secondly that access to eugenics may assist in the
functioning of a balanced and durable society’’ (p. 192). In
the following part, they raise objections against the new
eugenics. They argue that ‘‘in spite of the challenging
arguments above, many of the procedures involved in the
new eugenics should perhaps be excluded from biomedical
programs’’ (p. 211). At the center of the authors’ argument
is whether a person is worthy of living or not. For them, ‘‘if
all persons are equal in their inherent dignity, there is no
basis to select between them and it is difficult to state than
any life is unworthy of life.’’
The authors conclude that when approaching possibili-
ties of the new eugenics, one will have to choose between
two viewpoints: ‘‘Either a person is valued for their
inherent worth or they are valued for their quality of life. If
they are valued for their inherent worth, then the very act of
selection become meaningless since everyone is equal and
choosing no longer becomes necessary’’ (p. 296). Two
ideologies are at play here: the ‘‘worthiness of life’’ culture
and the ‘‘quality of life’’ culture. They side with the former,
because ‘‘A compassionate society should learn to accept
all possible future children in an environment that reflects
its unconditional and equal acceptance of the suffering as
well as the happy child’’ (p. 299). Finally, they present
practical recommendations on eugenics, which is the ‘‘first
example of guidelines from a European ethics council on
the topic of the new eugenics’’ (p. 301).
The book is clearly written, easy to follow and well-
researched. A lay audience will easily access and under-
stand the debate and realize what is at stake with the new
eugenics. Medical procedures and technical concepts are
well explained. It is a timely study that presents an
alternative to the increasingly prominent voices promoting
some type of new eugenics. This book provides a critical
perspective on promises of better health, better lives,
better children and a better society through biotechnology.
By reminding us of past eugenic atrocities, we are com-
pelled to wonder what are the atrocities that we could
embrace in the future, or the ones we already have,
despite our good intentions. Because good intentions
alone are not enough, as the authors remind us: ‘‘moti-
vation is a fragile guide to ethical correctness, not least
because it may easily be falsified or manipulated. Defin-
ing ethical appropriateness as synonymous with good
motives all but guarantees improper practices’’ (p. 188).
We ought to be cautious with these new possibilities, as
they require new responsibilities.
This book tells of the past so that the same mistakes will
not happen again. It is an essential read in order to
understand the historical and cultural climate in which the
new eugenics is coming from, and the book puts propo-
nents of these new technologies in their historical context.
If the book has any shortcomings, it might be because it
covers a lot of ground, and therefore some parts remain
only introductory. Nonetheless, each argument is well
presented so that we get the main points. It is a must read in
our day and age, especially when biotechnology and some
of its use could be a threat to all of humanity.
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Boniolo, G. and Maugeri, P. (eds.): 2014, Etica alle
frontiere della biomedicina. Milan: Mondadori Education.
278 pages. ISBN: 978-88-6184-312-7. Price: €20.
The increase in knowledge on the fundamental biological
processes, from the middle of the last century to present
times, has made great contributions to the disciplines
concerned with the improvement of human health on both
the individual and population level. It has permitted the
development of new drugs, therapies and diagnostic tools.
However, this continual progress in biomedical sciences—
which is the common name given to all these disciplines—
manifests itself in societies permeated with diversity of
values that often result in moral dilemmas and disagree-
ments. Consequently, it has also given rise to new and
pressing questions of ethical nature. This is especially
evident in the field of genomics, where rapid knowledge
advancements and the corresponding biotechnological
developments give rise to profound ethical questions in the
context of moral disagreements.
Ethics at the Frontiers of Biomedicine is a volume
produced by students and coordinators of the PhD Program
in Foundations and Ethics of the Life Sciences at the
European Institute of Oncology in Milan. The handbook
aims to provide a common ethical framework within which
the ethical issues arising from the progress in biomedical
sciences, and the regulatory challenges they pose, can be
articulated, critically examined and evaluated, and con-
structively dealt with. It was devised as an aid to deliber-
ation, serving as one of the instruments in the toolkit of the
good deliberator, and it covers various themes, from
embryonic stem cell research and synthetic biology to
animal experimentation and experimentation on human
subjects, from privacy and the right not to know to pater-
nalism and responsibility in individual and public health
settings.
Each chapter begins with plain but rigorous description
of the scientific background that characterizes the issue in
question; it then proposes an analysis of the conceptual
tools necessary for ethical discussion; and finally illustrates
the most important problems of the various proposed
solutions and ways to justify or criticize them in
argumentation.
Part 1 contains chapters on ethics and deliberative
democracy—it is an introductory part intended to provide
historical-methodological presentation to ethics, as a way
to form positive or negative judgments about human
behavior, and foundations of deliberative democracy, as a
way to reach decisions on matters of moral disagreements.
Part 2 of the book deals with various topics relating to
biomedical research: moral legitimacy and private versus
public interests in embryonic stem cells research on; ani-
mal experimentation; biobanks and clinical research
involving human subjects. Part 3 focuses on diagnosis and
therapy, and explores ethical questions arising in the fields
of regenerative medicine, genetic testing and reproductive
choices, and biomedical enhancements. The forth and final
part of the volume focuses on the public health sector and
addresses the issues of private versus public interests
through discussion of paternalism and responsibility, vac-
cination, life extension and eugenics.
Ethics at the Frontier of Biomedicine will equip stu-
dents of various disciplines, as well as interested citi-
zens, with the tools, conceptual and argumentative, that
enable them to develop their own positions regarding the
issues in question and provide well-constructed argu-
ments based on moral grounds, keeping the ideologies
and dogmas apart. The topics covered are carefully
chosen to answer to the particularities of the Italian
socio-cultural heritage within the wider European con-
text that strives to produce a common European‘‘iden-
tity’’. As such, it not only represents a unique and
essential empowering instrument for an Italian reader,
but also provides an equally important contribution to
the wider, European and international bioethical debates
in the academia and public at large.
Maria Damjanovicova
Milan, Italy
Thiel, M.-J.: 2013, Faites que je meure vivant! Vieillir, mourir,
vivre. Paris: Bayard. 239 pages. ISBN: 978-2227486270. Price:
€ 16.00.
The steady lengthening of life expectancy and the
increasing numbers of elderly in the population of indus-
trialized countries raise several issues about public health,
medical ethics, social support and intergenerational justice,
but it also raises the much more difficult question of how to
preserve the recognition of the other and the self when
aging comes.
The title of Marie-Jo Thiel’s book echoes the famous
British psychoanalyst Donald W. Winnicott, who at the
point of death noted in his diary, as a prayer: ‘‘Oh, God,
make me die alive!…’’ (p. 233). This sentence, which
cannot leave us indifferent, is the leitmotif of the book
which is the subject of this review. Marie-Jo Thiel is a
physician, a theologian, a graduated in health policy, and a
professor of ethics at the University of Strasbourg. By
combining these different areas of expertise, she contrib-
utes to a better understanding of aging, this ‘‘social con-
struct full of ambivalences’’ (p. 7) in which ‘‘the
acceptance of vulnerability remains a challenge’’ (p. 11).
The reflections made in this volume help also to
approach with more clarity the difficulties posed by old
Short literature notices 653
123
age, including the economic ones (‘‘the price of human’’,
p. 114). Moreover, the book contributes to address these
issues with serenity, recognizing the important role that
elderly people have always played in society as bearers of
wisdom and history (p. 106).
If ‘‘ageing is a reality that questions all of us’’ (chap.
1), especially at a time when society tends to exalt the
young (p. 39) and does not understand well the distresses
of ageing people (p. 50), the ‘‘ageing well while
advancing in life’’ (chapter 2) is possible when it is
based on solidarity between generations (p. 114) and
assigns a central role to respect for personal autonomy
(p. 126). Yet this recognition of the other is not auto-
matic (p. 77).
If the greater susceptibility to Alzheimer’s disease
(chapter 3), suffering (chapter 4) and disease in general
(chapter 5) are often companions of the elderly, many
challenges must be overcome and more particularly that of
the undeniable dignity of every human being (p. 144).
Facing suffering and illness leads to address ethical ques-
tions (p. 165), and to deal with a ‘‘theology of compassion’’
(p. 174), which literally means a ‘‘shared passion’’ (p. 164).
‘‘The only genuine compassion is the one that allows those
who suffer to be themselves, and moreover, to enter into a
dynamic of compassion towards their own suffering con-
dition’’ (p. 168).
Marie-Jo Thiel puts together three verbs (aging, dying,
living) that show the path to be taken: ‘‘when life has been
sown, living is the last phase and the one that remains’’ (p.
233). This is a provoking book, which challenges and
reassures in equal measure its readers.
Jacqueline Bouton
Strasbourg, France
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